Key facts
- This page summarizes Christian Claussen's Form 4 filing for Arteris, Inc. (AIP).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 29 Oct 2021, 20:28.
Christian Claussen - 26 Oct 2021 Form 4 Insider Report for Arteris, Inc. (AIP)
- Reporting relationship
- Director
- Issuer ticker
- AIP
- Reported as of
- 26 Oct 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ Paul Alpern as Attorney-in-fact for Christian Claussen
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Christian Claussen filed Form 4 for Arteris, Inc. (AIP) on 29 Oct 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AIP
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +3,127,907
- Change %
- Price
- Shares after
- 3,127,907
- Date
- 29 Oct 2021
- Ownership
- See Footnote
- Footnotes
- F1, F2
AIP
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +6,250
- Change %
- Price
- $0.000000
- Shares after
- 6,250
- Date
- 26 Oct 2021
- Ownership
- Direct
- Footnotes
- F3, F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AIP
transaction
Derivative
Series A Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -3,127,907
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 3,127,907
- Date
- 29 Oct 2021
- Ownership
- See Footnote
- Underlying class
- Common Stock
- Underlying amount
- 3,127,907
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.
Footnote F2
The reporting person is a General Partner of Ventech Capital F ("Ventech"). Investment and voting decisions for Ventech are made by Ventech's investment committee, which is governed by a non-executive board comprised of three or more individuals, and therefore the reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein, if any.
Footnote F3
Includes 6,250 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date.
Footnote F4
Includes 6,250 restricted stock units.